Competitive inhibition of Δ8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 4, 1998, Pages 408-410

  Yamamoto, Ikuo ^a   Kimura, Toshiyuki ^a   Kamei, Ayako ^a   Yoshida, Hisatoshi ^a   Watanabe, Kazuhito ^a   Ho, Ing Kang ^b   Yoshimura, Hidetoshi ^c  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

11 hydroxy 8 THC; 11 oxo 8 THC; Active metabolite; Cannabinoid receptor; CP 55940

Indexed keywords

CANNABINOID; TETRAHYDROCANNABINOL; CANNABINOID RECEPTOR; DRUG RECEPTOR; PSYCHEDELIC AGENT;

ARTICLE; BINDING AFFINITY; BINDING SITE; CATTLE; DATA ANALYSIS; LIGAND BINDING; RECEPTOR BINDING; SCATCHARD PLOT; ANIMAL; BINDING COMPETITION; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; OXIDATION REDUCTION REACTION; SYNAPTIC MEMBRANE;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CATTLE; HALLUCINOGENS; OXIDATION-REDUCTION; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SYNAPTIC MEMBRANES; TETRAHYDROCANNABINOL;

EID: 0031596925     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.408     Document Type: Article

References (18)

1. Agurell S., Halldin M., Lindgren J. -E., Ohlsson A., Widman M., Gillespie H., Hollister L., Pharmacol. Rev., 38, 21-74 (1986).
2. Harvey D. J., Paton W. D. M., Rev. Biochem. Toxicol., 6, 211-264 (1984).
3. Wilson R. S., May E. L., "Pharmacology of Marihuana", ed. by Braude M. C., Szara S., Raven Press, New York, 1976, pp. 137-138.
4. Wall M. E., Perez-Reyes M., J. Clin. Pharmacol., 21, 178S (1981).
5. Watanabe K., Yamamoto I., Oguri K., Yoshimura H., Eur. J. Pharmacol., 63, 1-6 (1980).
6. Watanabe K., Yamamoto I., Yoshimura H., Res. Commun. Subst. Abuse, 3, 21-28 (1982).
7. Christensen H. D., Freudenthal R. I., Gidley J. T., Rosenfeld R., Boegli G., Testino L., Brine D. R., Pitt C. G., Wall M. E., Science, 172, 165-167 (1971).
8. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., De Costa B. R., Rice K. C., Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936 (1990).
9. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I., Nature (London), 346, 561-564 (1990).
10. Compton D. R., Rice K. C., De Costa B. R., Razdan R. K., Melvin L. S., Johnson M. R., Martin B. R., J. Pharmacol. Exp. Ther., 265, 218-226 (1993).
11. Inayama S., Sawa A., Hosoya E., Chem. Pharm. Bull., 22, 1519-1525 (1974).
12. Mechoulam R., Ben-Zvi Z., Agurell S., Nilsson I. M., Nilsson J. L. G., Edery H., Grunfeld Y., Experientia, 29, 1193-1195 (1973).
13. Zukin S. R., Young A. B., Snyder S. H., Proc. Natl. Acad. Sci. U.S.A., 71, 4802-4807 (1974).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Devane W. A., Dysarz III F. A., Johnson M. R., Melvin L. S., Howlett A. C., Mol. Pharmacol., 34, 605-613 (1988).
16. Speth R. C., Wastek G. J., Johnson P. C., Yamamura H. I., Life Sci., 22, 859-866 (1978).
17. Mechoulam R., McCallum N. K., Burstein S., Chem. Rev., 76, 75-111 (1976).
18. Yamamoto I., Kimura T., Yoshida H., Watanabe K., Yoshimura H., Res. Commun. Subst. Abuse, 13, 299-313 (1992).